Security key
00650F109
Adaptive Biotechnologies Corp - Common Stock, par value $0.0001 per share (ADPT)
CUSIP: 00650F109
Q1 2025 13F Holders as of 31 Mar 2025
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 159,541,000
- Total 13F shares
- 152,930,142
- Share change
- +8,839,216
- Total reported value
- $1,136,093,247
- Put/Call ratio
- 108%
- Price per share
- $7.43
- Number of holders
- 222
- Value change
- +$68,698,942
- Number of buys
- 108
- Number of sells
- 84
Report period
Q1 2025
Institutions
222
Top holders
10
ADPT full security history
Newer quarter: Q2 2025
Previous quarter: Q4 2024
Adaptive Biotechnologies Corp SEC filings
Adaptive Biotechnologies Corp company facts
Broader feeds
Reporting periods
Holder history for CUSIP 00650F109
Recent filing periods:
Top shareholders of ADPT - Adaptive Biotechnologies Corp - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Amova Asset Management Americas, Inc. |
13D/G
13F
|
Nikko Asset Management Americas, Inc. · Company |
4.6%
|
6,833,137
|
$53,981,782 | $0 | 31 Dec 2024 | |
| Sumitomo Mitsui Trust Group, Inc. |
13D/G
13F
|
Company |
4.6%
|
6,833,137
|
$53,981,782 | $0 | 31 Dec 2024 | |
| INTEGRATED CORE STRATEGIES (US) LLC |
13D/G
|
Millennium Management LLC |
4.3%
|
6,292,634
|
$49,711,809 | $0 | 31 Dec 2024 | |
| VIKING GLOBAL INVESTORS LP |
13F
|
Company |
19%
|
29,993,708
|
$179,812,279 | — | 31 Dec 2024 | |
| Rubric Capital Management LP |
13F
|
Company |
9.2%
|
14,600,000
|
$87,527,000 | — | 31 Dec 2024 | |
| BlackRock, Inc. |
13F
|
Company |
7.6%
|
12,120,846
|
$72,664,472 | — | 31 Dec 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
6.7%
|
10,714,888
|
$64,235,753 | — | 31 Dec 2024 | |
| ARK Investment Management LLC |
13F
|
Company |
5.9%
|
9,424,074
|
$56,497,324 | — | 31 Dec 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
3.9%
|
6,292,634
|
$37,724,341 | — | 31 Dec 2024 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
2.1%
|
3,370,919
|
$20,208,659 | — | 31 Dec 2024 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
1.9%
|
2,983,142
|
$17,883,936 | — | 31 Dec 2024 | |
| Aristotle Atlantic Partners, LLC |
13F
|
Company |
1.8%
|
2,886,702
|
$17,305,780 | — | 31 Dec 2024 | |
| STATE STREET CORP |
13F
|
Company |
1.7%
|
2,729,901
|
$16,365,757 | — | 31 Dec 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.7%
|
2,684,506
|
$16,097,897 | — | 31 Dec 2024 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
1.5%
|
2,428,710
|
$14,560,117 | — | 31 Dec 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.4%
|
2,238,126
|
$13,417,566 | — | 31 Dec 2024 | |
| Blue Water Life Science Advisors, LP |
13F
|
Company |
1.3%
|
2,145,145
|
$12,860,144 | — | 31 Dec 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1%
|
1,604,876
|
$9,621,990 | — | 31 Dec 2024 | |
| Pier Capital, LLC |
13F
|
Company |
0.8%
|
1,274,293
|
$7,639,387 | — | 31 Dec 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.75%
|
1,193,835
|
$7,157,041 | — | 31 Dec 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.69%
|
1,093,981
|
$6,558,415 | — | 31 Dec 2024 | |
| Aberdeen Group plc |
13F
|
Company |
0.63%
|
1,004,059
|
$6,019,334 | — | 31 Dec 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.6%
|
956,574
|
$5,734,661 | — | 31 Dec 2024 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.59%
|
937,331
|
$5,619,302 | — | 31 Dec 2024 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.53%
|
846,171
|
$5,072,795 | — | 31 Dec 2024 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.46%
|
736,720
|
$4,416,636 | — | 31 Dec 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.41%
|
659,206
|
$3,951,941 | — | 31 Dec 2024 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.4%
|
630,577
|
$3,783,462 | — | 31 Dec 2024 | |
| ESSEX INVESTMENT MANAGEMENT CO LLC |
13F
|
Company |
0.39%
|
625,838
|
$3,751,899 | — | 31 Dec 2024 | |
| Clearline Capital LP |
13F
|
Company |
0.37%
|
586,780
|
$3,517,746 | — | 31 Dec 2024 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.3%
|
481,965
|
$2,889,380 | — | 31 Dec 2024 | |
| Cerity Partners LLC |
13F
|
Company |
0.3%
|
478,448
|
$2,475,801 | — | 31 Dec 2024 | |
| TUDOR INVESTMENT CORP ET AL |
13F
|
Company |
0.29%
|
458,488
|
$2,748,636 | — | 31 Dec 2024 | |
| ALGERT GLOBAL LLC |
13F
|
Company |
0.27%
|
430,514
|
$2,581,000 | — | 31 Dec 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.25%
|
406,587
|
$2,437,488 | — | 31 Dec 2024 | |
| UBS Group AG |
13F
|
Company |
0.25%
|
397,258
|
$2,381,562 | — | 31 Dec 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.23%
|
363,906
|
$2,181,619 | — | 31 Dec 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.22%
|
354,842
|
$2,127,277 | — | 31 Dec 2024 | |
| PDT Partners, LLC |
13F
|
Company |
0.2%
|
316,281
|
$1,896,105 | — | 31 Dec 2024 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.2%
|
315,098
|
$1,889,012 | — | 31 Dec 2024 | |
| Man Group plc |
13F
|
Company |
0.18%
|
288,689
|
$1,730,691 | — | 31 Dec 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.17%
|
266,066
|
$1,595,065 | — | 31 Dec 2024 | |
| FMR LLC |
13F
|
Company |
0.16%
|
255,738
|
$1,533,150 | — | 31 Dec 2024 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.15%
|
246,865
|
$1,480,000 | — | 31 Dec 2024 | |
| Cinctive Capital Management LP |
13F
|
Company |
0.15%
|
241,316
|
$1,446,689 | — | 31 Dec 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.15%
|
240,996
|
$1,444,771 | — | 31 Dec 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.14%
|
229,785
|
$1,377,561 | — | 31 Dec 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.14%
|
226,982
|
$1,360,757 | — | 31 Dec 2024 | |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) |
13F
|
Company |
0.13%
|
213,829
|
$1,281,905 | — | 31 Dec 2024 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.13%
|
212,828
|
$1,275,903 | — | 31 Dec 2024 |
Institutional Holders of Adaptive Biotechnologies Corp - Common Stock, par value $0.0001 per share (ADPT) as of Q1 2025
As of 31 Mar 2025,
Adaptive Biotechnologies Corp - Common Stock, par value $0.0001 per share (ADPT) was held by
222 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
152,930,142 shares.
The largest 10 holders included
VIKING GLOBAL INVESTORS LP, Rubric Capital Management LP, BlackRock, Inc., VANGUARD GROUP INC, ARK Investment Management LLC, AMERIPRISE FINANCIAL INC, Nikko Asset Management Americas, Inc., Sumitomo Mitsui Trust Group, Inc., BRAIDWELL LP, and MILLENNIUM MANAGEMENT LLC.
This page lists
222
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2025 vs Q4 2024 Across Filers
Q4 2024 holders
204
Q1 2025 holders
222
Holder diff
18
| Investor | Q4 2024 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q4 2024 Value $ | Q1 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.